CO6341552A2 - Combinacion farmaceutica que contiene el 6 - dimetilaminometil - 1 -(3-metoxi-fenil) - ciclohexano - 1, 3 - diol y paracetamol. - Google Patents

Combinacion farmaceutica que contiene el 6 - dimetilaminometil - 1 -(3-metoxi-fenil) - ciclohexano - 1, 3 - diol y paracetamol.

Info

Publication number
CO6341552A2
CO6341552A2 CO11021385A CO11021385A CO6341552A2 CO 6341552 A2 CO6341552 A2 CO 6341552A2 CO 11021385 A CO11021385 A CO 11021385A CO 11021385 A CO11021385 A CO 11021385A CO 6341552 A2 CO6341552 A2 CO 6341552A2
Authority
CO
Colombia
Prior art keywords
paracetamol
phenyl
diol
pharmaceutical combination
dimetilaminometil
Prior art date
Application number
CO11021385A
Other languages
English (en)
Inventor
Petra Bloms-Funke
Klaus Schiene
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40328601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6341552(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of CO6341552A2 publication Critical patent/CO6341552A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una combinación formada por (a) por lo menos un componente 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y (b) el paracetamol o un derivado del mismo; una combinación farmacéutica y una forma de dosificación que contiene dicha combinación así como un método para tratar uno o más de dolor y osteoartritis en un mamífero, caracterizada porque los componentes (a) y (b) se administran simultánea o sucesivamente a dicho mamífero, dicho componente (a) puede administrarse antes o después del componente (b) y dichos componentes (a) o (b) se administran al mamífero por la misma vía o por vías diferentes.
CO11021385A 2008-09-05 2011-02-22 Combinacion farmaceutica que contiene el 6 - dimetilaminometil - 1 -(3-metoxi-fenil) - ciclohexano - 1, 3 - diol y paracetamol. CO6341552A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08015621 2008-09-05

Publications (1)

Publication Number Publication Date
CO6341552A2 true CO6341552A2 (es) 2011-11-21

Family

ID=40328601

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11021385A CO6341552A2 (es) 2008-09-05 2011-02-22 Combinacion farmaceutica que contiene el 6 - dimetilaminometil - 1 -(3-metoxi-fenil) - ciclohexano - 1, 3 - diol y paracetamol.

Country Status (19)

Country Link
US (1) US20100069501A1 (es)
EP (1) EP2331087A1 (es)
JP (1) JP2012501985A (es)
KR (1) KR20110059634A (es)
CN (1) CN102202660A (es)
AR (1) AR073277A1 (es)
AU (1) AU2009289824A1 (es)
BR (1) BRPI0918566A2 (es)
CA (1) CA2735855A1 (es)
CL (1) CL2011000387A1 (es)
CO (1) CO6341552A2 (es)
EC (1) ECSP11010876A (es)
IL (1) IL211395A0 (es)
MX (1) MX2011002430A (es)
NZ (1) NZ591419A (es)
PE (1) PE20110799A1 (es)
RU (1) RU2011112443A (es)
WO (1) WO2010025930A1 (es)
ZA (1) ZA201101669B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US20130310435A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69226624T3 (de) * 1991-09-06 2009-11-05 Ortho-Mcneil Pharmaceutical, Inc. Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
CN1349423A (zh) * 1999-03-01 2002-05-15 奥索-麦克尼尔药品公司 包含曲马多物质和选择性cox－2抑制剂药物的组合物
SI1839654T1 (sl) * 2002-11-22 2010-08-31 Gruenenthal Gmbh Uporaba (1R, 2R)-3-(3-dimetilamino-1-etil-2-metil- propil)-fenola za zdravljenje vnetne bolečine

Also Published As

Publication number Publication date
AR073277A1 (es) 2010-10-28
BRPI0918566A2 (pt) 2016-02-10
PE20110799A1 (es) 2011-11-10
RU2011112443A (ru) 2012-10-10
ZA201101669B (en) 2011-11-30
CL2011000387A1 (es) 2011-06-17
ECSP11010876A (es) 2011-04-29
WO2010025930A1 (en) 2010-03-11
US20100069501A1 (en) 2010-03-18
KR20110059634A (ko) 2011-06-02
AU2009289824A1 (en) 2010-03-11
CN102202660A (zh) 2011-09-28
JP2012501985A (ja) 2012-01-26
CA2735855A1 (en) 2010-03-11
NZ591419A (en) 2011-11-25
MX2011002430A (es) 2011-04-05
EP2331087A1 (en) 2011-06-15
IL211395A0 (en) 2011-05-31

Similar Documents

Publication Publication Date Title
AR117613A2 (es) Combinación farmacéutica
ECSP19047259A (es) Combinación farmacéutica para el tratamiento del dolor
UY35210A (es) Inhibidores de autotaxina
GT201500021A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
UY32925A (es) Composiciones de corticosteroides de administración oral
CL2015001389A1 (es) Composiciones y compuestos antihelmínticos y métodos para usarlos.
ECSP14013315A (es) Inhibidores de aplicación viral
CO6551683A2 (es) Tratamiento para trastornos gastrointestinales
BR112015001101A2 (pt) formas cristalinas de um inibidor de prolil hidroxilase
GT201300174A (es) Compuestos de indol o análogos de los mismos útiles para el tratamiento de la degeneración macular relacionada con la edad (dme)
GT201400111A (es) Triazolopiridinas sustituidas
CR20190162A (es) Métodos para usar un anticuerpo biespecífico que reconoce el factor de coagulación ix y/o el factor de coagulación ix activado y el factor de coagulación x y/o el factor de coagulación x activado
CO6761335A2 (es) Inhibidores del virus de la hepatitis c
DOP2016000253A (es) Nuevos compuestos
CR11418A (es) Trans-clomifeno para el sindrome metabolico
UY32776A (es) Compuestos de imidazopirazinas sustituidas para el tratamiento de enfermedades parasitarias,composiciones farmacéuticas que los contienen y aplicación.
CO6341550A2 (es) Combinacion farmaceutica que contiene el 6 - dimetilaminometil - 1 - (3-metoxi-fenil) - ciclohexano - 1,3 - diol y un nsaid.
ECSP13013012A (es) Análogos del ácido epoxieicosatrienoicos y métodos de preparación
UY32704A (es) Compuestos de 2,3-dihidro-1h-indeno
ECSP11010876A (es) Combinación farmacéutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol
AR077987A1 (es) Combinacion farmaceutica que comprende 6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol o 6-dimetilaminometil-1-(3-hidroxifenil)-ciclohexano-1,3-diol y un antiepileptico
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
BR112017004304A2 (pt) composições de pteroestilbeno tópicas para uso em tratamento de perda de função de barreira na pele induzidas por uv
DOP2013000004A (es) Agentes terapeuticos 976
CL2015000778A1 (es) Composición farmacéutica oral sinérgica que comprende nitazoxanida y mebendazol; proceso de preparación; y uso para el tratar parasitosis humana provocada por protozoos y helmintos.

Legal Events

Date Code Title Description
FA Application withdrawn